Literature DB >> 11709780

Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.

S M Hsieh1, S C Pan, C C Hung, H C Tsai, M Y Chen, S C Chang.   

Abstract

The association between cytomegalovirus (CMV)-specific reactivity of T cell subsets and development of CMV retinitis (CMV-R) was prospectively studied in 50 CMV-seropositive AIDS patients. The frequency of CMV-specific CD69 expression on CD8 T cells was similar in patients with and patients without CMV-R (median, 1.0% vs. 1.2%; P=.14). However, the frequency of CMV-specific CD69 expression on CD4 T cells was significantly lower in patients with CMV-R than in those without CMV-R (median, 0.4% vs. 2.25%; P<.001). CMV-specific CD4 T cell reactivity in patients who developed CMV-R shortly after starting highly active antiretroviral therapy (HAART) remained low, although the CD4 cell counts increased markedly. Therefore, development of CMV-R is associated with a poor CMV-specific reactivity of CD4 T cells but not with poor reactivity of CD8 T cells. Development of CMV-R after initiation of HAART is associated with a poor reconstitution of CMV-specific immune response, rather than with immune rebound.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709780     DOI: 10.1086/324419

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.

Authors:  G C Harcourt; T J Scriba; N Semmo; S Bounds; E Taylor; P Klenerman
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 2.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

3.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

Review 4.  New tools to study the role of B cells in cytomegalovirus infections.

Authors:  Ari Waisman; Andrew L Croxford; Filiz Demircik
Journal:  Med Microbiol Immunol       Date:  2008-03-11       Impact factor: 3.402

5.  Chronic Retinal Necrosis Severely Complicated by Neovascular Glaucoma: A Case Report.

Authors:  Takanori Matsuoka; Kazunobu Asao; Noriyasu Hashida; Kohji Nishida
Journal:  Case Rep Ophthalmol       Date:  2017-10-26

6.  Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.

Authors:  Denise C Hsu; Stephen J Kerr; Thatri Iampornsin; Sarah L Pett; Anchalee Avihingsanon; Parawee Thongpaeng; John J Zaunders; Sasiwimol Ubolyam; Jintanat Ananworanich; Anthony D Kelleher; David A Cooper
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.